{"id":"W3007309254","doi":"10.1177/2047487320905185","title":"Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab","year":2020,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"University of California, San Diego; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Internal medicine; Cholesterol; Endocrinology; Ezetimibe; Triglyceride; High-density lipoprotein; Lipoprotein; Placebo; Statin; Apolipoprotein A1","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01098707,0.0006294822,0.001928944,0.0002912518,0.0003933303,0.00113998,0.0003650269,0.0005125477,0.002497671],"category_scores_gemma":[0.01017664,0.0003641062,0.003289497,0.0004532216,0.0005617097,0.0007958142,0.0007349135,0.001541748,0.00020043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006973977,"about_ca_system_score_gemma":0.001717872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001400322,"about_ca_topic_score_gemma":0.003892393,"domain_scores_codex":[0.9949088,0.003883865,0.0003959838,0.000328858,0.0002520197,0.0002305334],"domain_scores_gemma":[0.9944192,0.002789002,0.001650456,0.0003416453,0.0003474118,0.0004522505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.8668147,0.001891839,0.03679589,0.004237605,0.01118475,0.0001283976,0.0004286862,0.002187276,0.006193542,0.0007721481,0.002664171,0.06670089],"study_design_scores_gemma":[0.5442591,0.1436593,0.2435201,0.001791105,0.03114721,0.0006440254,0.0004164667,0.008702544,0.007836537,0.004404342,0.01339909,0.0002200972],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9672899,0.02473022,0.002127531,0.001012801,0.0001181816,0.001164375,0.001444895,0.00006482802,0.002047164],"genre_scores_gemma":[0.9917743,0.002704174,0.002400716,0.0006352141,0.0000525904,0.001238705,0.0006819966,0.00002140113,0.0004910439],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01098707,"threshold_uncertainty_score":0.05810589,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03147206141299505,"score_gpt":0.3002676256073128,"score_spread":0.2687955641943177,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}